For: | Talebi Bezmin Abadi A. Vaccine against Helicobacter pylori: Inevitable approach. World J Gastroenterol 2016; 22(11): 3150-3157 [PMID: 27003991 DOI: 10.3748/wjg.v22.i11.3150] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v22/i11/3150.htm |
Number | Citing Articles |
1 |
Alejandro Venegas, Jorge Hantar Touma, Jessica Bravo, Guillermo Perez-Perez. Progress in Use of Natural Products and Their Active Components against <i>Helicobacter pylori</i>. Advances in Microbiology 2016; 6(14): 1091 doi: 10.4236/aim.2016.614101
|
2 |
Paola Cappello, Sara Bulfamante, Giorgia Mandili, Francesco Novelli. Cancer Immunoprevention. Methods in Molecular Biology 2022; 2435: 19 doi: 10.1007/978-1-0716-2014-4_3
|
3 |
May A. Beydoun, Hind A. Beydoun, Martine Elbejjani, Gregory A. Dore, Alan B. Zonderman. Helicobacter pylori seropositivity and its association with incident all‐cause and Alzheimer's disease dementia in large national surveys. Alzheimer's & Dementia 2018; 14(9): 1148 doi: 10.1016/j.jalz.2018.04.009
|
4 |
Amir Ghasemi, Shifeng Wang, Bikash Sahay, Jeffrey R. Abbott, Roy Curtiss. Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1034683
|
5 |
Ahmad Shafiee, Massoud Amini, Hassan Emamirad, Amin Talebi Bezmin Abadi. Recombination and phenotype evolution dynamics of Helicobacter pylori in colonized hosts. International Journal of Systematic and Evolutionary Microbiology 2016; 66(7): 2471 doi: 10.1099/ijsem.0.001072
|
6 |
Amin Talebi Bezmin Abadi, Yeong Yeh Lee. Chinese <i>Helicobacter pylori</i> vaccine: Solution for an old challenge?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(3): 412-415 doi: 10.4292/wjgpt.v7.i3.412
|
7 |
Amin Talebi Bezmin Abadi, Celebi Kocaoglu. Lack of evidence for Helicobacter pylori to prevent children growth efficiently. World Journal of Pediatrics 2016; 12(4): 506 doi: 10.1007/s12519-016-0059-1
|
8 |
Alireza Salimi Chirani, Mona Ghazi, Mehdi Goudarzi, Shahin Najar Peerayeh, Hoorieh Soleimanjahi, Masoud Dadashi, Bahareh Hajikhani. A survey on chimeric UreB229-561-HpaA protein targeting Helicobacter pylori: Computational and in vitro urease activity valuation. Computational Biology and Chemistry 2018; 76: 42 doi: 10.1016/j.compbiolchem.2018.05.001
|
9 |
Hadi Maleki-Kakelar, Jaber Dehghani, Abolfazl Barzegari, Jaleh Barar, Masoud Shirmohamadi, Javid Sadeghi, Yadollah Omidi.
Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori. BioImpacts 2019; 10(2): 65 doi: 10.34172/bi.2020.09
|
10 |
Lyudmila Boyanova, Petyo Hadzhiyski, Nayden Kandilarov, Rumyana Markovska, Ivan Mitov. Multidrug resistance inHelicobacter pylori: current state and future directions. Expert Review of Clinical Pharmacology 2019; 12(9): 909 doi: 10.1080/17512433.2019.1654858
|
11 |
Stella G. Hoft, Christine N. Noto, Richard J. DiPaolo. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.752346
|
12 |
Han-Yi Song, Long Zhou, Dong-yan Liu, Xin-Jie Yao, Yan Li. What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9379480
|
13 |
Stella Smith, Muinah Fowora, Rinaldo Pellicano. Infections with <i>Helicobacter pylori</i> and challenges encountered in Africa. World Journal of Gastroenterology 2019; 25(25): 3183-3195 doi: 10.3748/wjg.v25.i25.3183
|
14 |
Katarzyna Macegoniuk, Ewa Grela, Monika Biernat, Mateusz Psurski, Grażyna Gościniak, Anna Dziełak, Artur Mucha, Joanna Wietrzyk, Łukasz Berlicki, Agnieszka Grabowiecka, Anna Roujeinikova. Aminophosphinates against Helicobacter pylori ureolysis—Biochemical and whole-cell inhibition characteristics. PLOS ONE 2017; 12(8): e0182437 doi: 10.1371/journal.pone.0182437
|
15 |
Variya Nemidkanam, Yuko Kato, Tetsuo Kubota, Nuntaree Chaichanawongsaroj. Ethyl acetate extract of Kaempferia parviflora inhibits Helicobacter pylori-associated mammalian cell inflammation by regulating proinflammatory cytokine expression and leukocyte chemotaxis. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-02927-2
|
16 |
Doaa M. AlEraky, Hatem M. Abuohashish, Amr S. Bugshan, Maha M. Abdelsalam, Hussain A. AlHawaj, Taleb T. AlKhamis, Fatimah A. AlDossary, Nabras M. Alrayes, Yasser M. Ragab, Zeinab AbdelKhalek, Omneya M. Helmy, Mohammed A. Ramadan. Potential Antigenic Candidates for the Development of Peptide-Based Vaccines to Induce Immunization against Helicobacter pylori Infection in BALB/c Mice. International Journal of Molecular Sciences 2022; 23(21): 12824 doi: 10.3390/ijms232112824
|
17 |
Raluca Ioana Dascălu, Alexandra Bolocan, Dan Nicolae Păduaru, Alexandru Constantinescu, Magda Mihaela Mitache, Anca Daniela Stoica, Octavian Andronic. Multidrug resistance in Helicobacter pylori infection. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1128497
|
18 |
Amin Talebi Bezmin Abadi. Not an easy road to generate an effective Helicobacter pylori vaccine. Infection, Genetics and Evolution 2017; 51: 45 doi: 10.1016/j.meegid.2017.03.010
|
19 |
Ayub Ali, Nazrul Islam, Nazrul Islam Fakir, Ahsan Kabir, Mowmita Sharmin, Tazul Islam, Masudur Rahman, Fakrul Amin Badal, Abu Taher. The Science Underlying the Probiotic Strain Bifidobacterium in Beneficial Effects on Immunological and Gastrointestinal Health. International Journal of Immunology 2024; 12(1): 10 doi: 10.11648/j.iji.20241201.12
|
20 |
Masoud Keikha, Mohsen Karbalaei. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01977-1
|
21 |
Xiaoyan Peng, Rongguang Zhang, Guangcai Duan, Chen Wang, Nan Sun, Linghan Zhang, Shuaiyin Chen, Qingtang Fan, Yuanlin Xi. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24879-x
|
22 |
Zhaoxiong Zhang, Wenxin Zhang, Xin Liu, Yongjia Yan, Weihua Fu. T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14670
|
23 |
N. N. Besednova, T. A. Kuznetsova, T. S. Zaporozhets, S. P. Kryzhanovsky, A. K. Gazha, E. Yu. Dobryakov, T. N. Zvyagintseva. The Influence of Polysaccharides from Sea Algae on the Pathogenetic Targets of <i>Helicobacter Pylori</i> — a New Direction in Therapy and Prevention of Infection. Antibiotics and Chemotherapy 2020; 65(1-2): 44 doi: 10.37489/0235-2990-2020-65-1-2-44-53
|
24 |
Irena Mladenova. Clinical Relevance of Helicobacter pylori Infection. Journal of Clinical Medicine 2021; 10(16): 3473 doi: 10.3390/jcm10163473
|
25 |
Hanchi Zhang, Zhili Liu, Yi Li, Ziwei Tao, Lu Shen, Yinpan Shang, Xiaotian Huang, Qiong Liu.
Adjuvants for
Helicobacter pylori
vaccines: Outer membrane vesicles provide an alternative strategy
. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2425773
|
26 |
Zifan Song, Biaoxian Li, Yingxuan Zhang, Ruizhen Li, Huan Ruan, Jing Wu, Qiong Liu. Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.01340
|
27 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
28 |
Xin Zhang, Shuli Sang, Qing Guan, Haoxia Tao, Yanchun Wang, Chunjie Liu. Oral Administration of a Shigella 2aT32-Based Vaccine Expressing UreB-HspA Fusion Antigen With and Without Parenteral rUreB-HspA Boost Confers Protection Against Helicobacter pylori in Mice Model. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.894206
|
29 |
Irineu Dos Santos Viana, Maria Luísa Cordeiro Santos, Hanna Santos Marques, Vinícius Lima de Souza Gonçalves, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Natália Oliveira e Silva, Fillipe Dantas Pinheiro, Adriano Fernandes Teixeira, Davi Tanajura Costa, Briza Oliveira Souza, Cláudio Lima Souza, Márcio Vasconcelos Oliveira, Fabrício Freire de Melo. Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape. Expert Review of Vaccines 2021; 20(8): 989 doi: 10.1080/14760584.2021.1945450
|
30 |
Enzo Ierardi, Giuseppe Losurdo, Rosa Federica La Fortezza, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo. Optimizing proton pump inhibitors in <i>Helicobacter pylori</i> treatment: Old and new tricks to improve effectiveness. World Journal of Gastroenterology 2019; 25(34): 5097-5104 doi: 10.3748/wjg.v25.i34.5097
|
31 |
Amir Ghasemi, Nazanin Mohammad, Josef Mautner, Mehrnaz Taghipour Karsabet, Jafar Amani, Abolfazl Ardjmand, Zarichehr Vakili. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection. Vaccine 2018; 36(34): 5124 doi: 10.1016/j.vaccine.2018.07.033
|
32 |
Viana Dayhimi, Fatemeh Ziadlou, Simin Nafian, Fatemeh Nafian. An Immunoinformatic Approach to Designing a Multi-epitope Vaccine against Helicobacter pylori with the VacA Toxin and BabA Adhesion. Current Proteomics 2024; 21(2): 97 doi: 10.2174/0115701646302487240524103934
|
33 |
Amir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis-Lorente, Chenguang Liu, Matthias G. Wacker, Ismaeil Haririan, Hamid Asadzadeh Aghdaei, Michael R. Hamblin, Abbas Yadegar, Mazda Rad-Malekshahi, Mohammad Reza Zali. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.917184
|
34 |
Amin Talebi Bezmin Abadi, Celebi Kocaoglu. Correspondence. World Journal of Pediatrics 2016; 12(4): 506 doi: 10.1007/s12519-016-0060-8
|
35 |
Kareem A. Ibrahim, Mohamed K. El-Ashrey, Mona T. Kashef, Omneya M. Helmy. Alanine racemase a promising Helicobacter pylori drug target inhibited by propanoic acid. Microbes and Infection 2023; 25(7): 105167 doi: 10.1016/j.micinf.2023.105167
|
36 |
Judeng Zeng, Chuan Xie, Lin Zhang, Xiaodong Liu, Matthew Tak Vai Chan, William Ka Kei Wu, Huarong Chen. Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies. International Journal of Molecular Sciences 2022; 23(18): 10941 doi: 10.3390/ijms231810941
|
37 |
M. Nasr-Esfahani, A. Doosti, M. S. Jami. Chitosan Nanoparticles-Mediated pCDNA3.1(–)-hcpD DNA Vaccine against Helicobacter pylori in BALB/c Mice. Molecular Genetics, Microbiology and Virology 2019; 34(2): 131 doi: 10.3103/S0891416819020083
|
38 |
Min Sun, Yu Liu, Xiumei Ni, Runqing Tan, Yi Wang, Yajun Jiang, Dingxin Ke, Han Du, Gang Guo, Kaiyun Liu. Intranasal immunization with poly I:C and CpG ODN adjuvants enhances the protective efficacy against Helicobacter pylori infection in mice. Microbes and Infection 2024; : 105433 doi: 10.1016/j.micinf.2024.105433
|
39 |
Meiying Liu, Youxiu Zhong, Jing Chen, Yu Liu, Chongfa Tang, Xuewei Wang, Yanbin Zhang, Ping Wang, Susan M. Logan, Wangxue Chen, Bo Wei. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine 2020; 38(14): 3031 doi: 10.1016/j.vaccine.2020.02.036
|
40 |
Amin Talebi Bezmin Abadi. Strategies used by <i>helicobacter pylori</i> to establish persistent infection. World Journal of Gastroenterology 2017; 23(16): 2870-2882 doi: 10.3748/wjg.v23.i16.2870
|
41 |
Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles. Bugs as Drugs. 2018; : 73 doi: 10.1128/9781555819705.ch3
|
42 |
Amin Talebi Bezmin Abadi, Guillermo Perez-Perez. Role of <i>dupA</i> in virulence of <i>Helicobacter pylori</i>. World Journal of Gastroenterology 2016; 22(46): 10118-10123 doi: 10.3748/wjg.v22.i46.10118
|
43 |
Xiaodong Wang, Yu Liu, Yuwen Diao, Ningning Gao, Yanyan Wan, Jingjing Zhong, Huali Zheng, Zhulin Wang, Guangyi Jin. Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1501-z
|
44 |
Stephanie Longet, Aine Abautret-Daly, Christopher J. H. Davitt, Craig P. McEntee, Vincenzo Aversa, Monica Rosa, Ivan S. Coulter, Jan Holmgren, Sukanya Raghavan, Ed C. Lavelle. An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses. npj Vaccines 2019; 4(1) doi: 10.1038/s41541-019-0139-z
|
45 |
Kareem A. Ibrahim, Mona T. Kashef, Tharwat R. Elkhamissy, Mohammed A. Ramadan, Omneya M. Helmy. Aspartate α-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1019666
|
46 |
Ahmad Karkhah, Soheil Ebrahimpour, Maryam Rostamtabar, Veerendra Koppolu, Sorena Darvish, Veneela Krishna Rekha Vasigala, Majid Validi, Hamid Reza Nouri. Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases. Microbiological Research 2019; 218: 49 doi: 10.1016/j.micres.2018.09.011
|
47 |
Yanchun Gao, Ruihong Wang, Lin Liu, Shitao Feng, Xiaozhi Xi, Wengong Yu, Yuchao Gu, Ye Wang. Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA. Artificial Cells, Nanomedicine, and Biotechnology 2023; 51(1): 509 doi: 10.1080/21691401.2023.2255635
|
48 |
Gracia M. Martin-Nuñez, Isabel Cornejo-Pareja, Mercedes Clemente-Postigo, Francisco J. Tinahones. Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.639856
|
49 |
Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles, Robert Allen Britton, Patrice D. Cani. Bifidobacteria and Their Health-Promoting Effects. Microbiology Spectrum 2017; 5(3) doi: 10.1128/microbiolspec.BAD-0010-2016
|
50 |
Sandra Salillas, Miriam Alías, Valérie Michel, Alejandro Mahía, Ainhoa Lucía, Liliana Rodrigues, Jessica Bueno, Juan José Galano-Frutos, Hilde De Reuse, Adrián Velázquez-Campoy, José Alberto Carrodeguas, Carlos Sostres, Javier Castillo, José Antonio Aínsa, María Dolores Díaz-de-Villegas, Ángel Lanas, Eliette Touati, Javier Sancho. Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice. Journal of Medicinal Chemistry 2019; 62(13): 6102 doi: 10.1021/acs.jmedchem.9b00355
|
51 |
Amin Talebi Bezmin Abadi. Helicobacter pylori and Gastric Cancer. Frontiers in Medicine 2016; 3 doi: 10.3389/fmed.2016.00036
|
52 |
Abbas Shapouri Moghaddam, Kiarash Ghazvini, Abbas Bahador, Mohammad Derakhshan, Azad Khaledi. Cloning, expression, and purification of HpaA-CagA fusion recombinant protein of Helicobacter pylori in E. coli BL 21 strain. Gene Reports 2019; 16: 100417 doi: 10.1016/j.genrep.2019.100417
|
53 |
Mehran Nemattalab, Mohammad Shenagari, Mojtaba Taheri, Mohammad Mahjoob, Foroogh Nazari Chamaki, Ali Mojtahedi, Elham Hasan-alizadeh, Babak Ashrafkhani, Neda Mousavi Niri. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine 2020; 126: 154866 doi: 10.1016/j.cyto.2019.154866
|
54 |
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategies. Critical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
|